Batf3−/− mice developed aggravated hepatic steatosis, inflammation, and fibrosis, accompanied by enhanced adipose lipolysis, increased hepatic fatty acid uptake, and impaired insulin-AKT signaling. Here, INS is linked to fatty liver disease.